Chemoinformaics analysis of Adenostemmoic acid B
| Molecular Weight | 348.439 | nRot | 1 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 22 |
| Exact Molecular Weight | 348.194 | nRing | 4 |
| Solubility: LogS | -3.161 | nHRing | 0 |
| Solubility: LogP | 1.164 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 56.0802 |
| nHD | 3 | BPOL | 29.8258 |
| QED | 0.632 |
| Synth | 5.991 |
| Natural Product Likeliness | 3.157 |
| NR-PPAR-gamma | 0.126 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.005 |
| HIA | 0.028 |
| CACO-2 | -5.437 |
| MDCK | 0.0000158 |
| BBB | 0.862 |
| PPB | 0.692649 |
| VDSS | 0.336 |
| FU | 0.332646 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.527 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.645 |
| CYP2c9-inh | 0.052 |
| CYP2c9-sub | 0.116 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.109 |
| CYP3a4-inh | 0.068 |
| CYP3a4-sub | 0.144 |
| CL | 1.749 |
| T12 | 0.667 |
| hERG | 0.068 |
| Ames | 0.232 |
| ROA | 0.941 |
| SkinSen | 0.872 |
| Carcinogencity | 0.757 |
| EI | 0.076 |
| Respiratory | 0.976 |
| NR-Aromatase | 0.882 |
| Antiviral | Yes |
| Prediction | 0.556963 |